| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Mai―30 |
Exploratory comparison of PASC and SARS-CoV-2 infection through metabolomics and lipidomics in early pandemic and Omicron-era |
Chelsea M. Rock, Laura M. Johnson, Adrianna L. Westbrook, Richard Parsons, John D. Roback, Gregory L. Damhorst, Wilbur A. Lam, Greg S. Martin, Madelyn C. Houser, Jennifer K. Frediani |
| 2 |
[GO] |
2026―Mrz―10 |
Persistent prostaglandin E2 upregulation and hormonal multi-resistance: A hypothesis for long COVID |
Vjera Ramer, Gert A. van Montfrans |
| 3 |
[GO] |
2026―Feb―18 |
Monocyte chemoattractant protein-1 (MCP-1/CCL2) and matrix metalloproteinase-9 (MMP-9) as biomarkers of disease severity in COVID-19 patients |
Kiarash Saleki, Moein Shirzad, Sheyda Mohammadkhani, Mostafa Javanian, Morteza Oladnabi, Abbas Azadmehr |
| 4 |
[GO] |
2025―Nov―20 |
Decoding the interplay between COVID-19 and diabetic nephropathy through bioinformatics and systems biology techniques |
Xianxiang Chen, Qingle Zeng, Min Xia, Yufen Chen |
| 5 |
[GO] |
2025―Okt―19 |
Investigation of Epstein-Barr virus coinfection and changes in the gene expression of angiotensin converting enzyme II in peripheral blood mononuclear cells in COVID-19 patients |
Hossein Lajmiri, Nioosha Ahmadi, Saeedeh Ebrahimi, Hadi Razavi Nikoo, Mehrdad Farrokhnia, Elham Heidari, Elham Mousavi |
| 6 |
[GO] |
2025―Apr―05 |
Differential clearance rate of proteins encoded on a self-amplifying mRNA COVID-19 vaccine in muscle and lymph nodes |
Reo Kanechi, Tatsuya Shishido, Mana Tachikawa, Tomohiro Nishimura, Akihito Sawada, Hayato Okade, Daisuke Ishikawa, Hitoshi Yamaguchi, Marito Araki |
| 7 |
[GO] |
2025―Mrz―13 |
In silico studies to understand the interactions of flavonoid inhibitor with nsp12-RNA dependent RNA polymerase of SARS-CoV-2 and its homologs |
Shamiya Anwar Kizhakkiniyakath, Tejaswini Choudhury, Madhan Vishal Rajan, Sagar Rathee, Basant Meena, Gururao Hariprasad |
| 8 |
[GO] |
2024―Dez―17 |
Assessing the prevalence of neutralizing antibodies (NAbs) to SARS-CoV-2 during three years of the COVID-19 pandemic |
Marina dos Santos Barreto, Ronaldy Santana Santos, Eloia Emanuelly Dias Silva, Deise Maria Rego Rodrigues Silva, Pedro Henrique Macedo Moura, Pamela Chaves de Jesus, Jessiane Bispo de Souza, Lucas Alves da Mota Santana, Adriana Gibara Guimarães, Lysandro Pinto Borges |
| 9 |
[GO] |
2024―Aug―20 |
Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells |
Vitoria Mattos Pereira, Amit Thakar, Sreejayan Nair |
| 10 |
[GO] |
2024―Aug―05 |
Insilico assessment of hesperidin on SARS-CoV-2 main protease and RNA polymerase: Molecular docking and dynamics simulation approach |
Elaheh Molaakbari, Mohammad Reza Aallae, Fereshteh Golestanifar, Zahra Garakani-Nejad, Ahmad Khosravi, Mohsen Rezapour, Rahime Eshaghi Malekshah, Mahsa Ghomi, Guogang Ren |
| 11 |
[GO] |
2024―Jun―13 |
Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches |
Cena Aram, Parsa Alijanizadeh, Kiarash Saleki, Leila Karami |
| 12 |
[GO] |
2024―Apr―29 |
Micro-second time-resolved X-ray single-molecule internal motions of SARS-CoV-2 spike variants |
Daisuke Sasaki, Tatsuya Arai, Yue Yang, Masahiro Kuramochi, Wakako Furuyama, Asuka Nanbo, Hiroshi Sekiguchi, Nobuhiro Morone, Kazuhiro Mio, Yuji C. Sasaki |
| 13 |
[GO] |
2023―Dez―26 |
Syringa reticulata potently inhibits the activity of SARS-CoV-2 3CL protease |
Zhichao Hao, Yuan Liu, Wei Guan, Juan Pan, MengMeng Li, Jiatong Wu, Yan Liu, Haixue Kuang, Bingyou Yang |
| 14 |
[GO] |
2023―Nov―02 |
Expression patterns of lncRNA MALAT-1 in SARS-COV-2 infection and its potential effect on disease severity via miR-200c-3p and SIRT1 |
Olfat Shaker, Monica El Amir, Yasmine Abd Elfatah, Heba M. Elwi |
| 15 |
[GO] |
2023―Jun―02 |
Identification of potential biomarkers to predict organ morbidity in COVID-19: A repository based proteomics perspective |
Sabyasachi Bandyopadhyay, Madhan Vishal Rajan, Punit Kaur, Gururao Hariprasad |
| 16 |
[GO] |
2023―Apr―25 |
Dried blood spot eluates are suitable for testing of SARS-CoV-2 IgG antibodies targeting Spike protein 1 and Nucleocapsid protein |
Sarah Guttmann, Sebastian Bunte, Simon Eschrig, Nils Janzen, Julia Klemens, Yara Koenemann, Dieter Münstermann, Thomas Neisse, Tim Niedergassel, Katja Steinhagen, Kristin Maria Meyer-Schlinkmann |
| 17 |
[GO] |
2023―Mrz―07 |
Blood levels of d-amino acids reflect the clinical course of COVID-19 |
Shihoko Kimura-Ohba, Yoshitsugu Takabatake, Atsushi Takahashi, Yoko Tanaka, Shinsuke Sakai, Yoshitaka Isaka, Tomonori Kimura |
| 18 |
[GO] |
2022―Nov―23 |
In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43 |
Paul Lang, Svend S. Geertsen, Alex L. Lublin, Michelle C. Potter, Tatiana Gladysheva, Jill S. Gregory, Pascal Rufi |
| 19 |
[GO] |
2022―Nov―07 |
Comparison of the inactivation capacity of various UV wavelengths on SARS-CoV-2 |
Ryosuke Matsuura, Chieh-Wen Lo, Takayo Ogawa, Masaru Nakagawa, Masami Takei, Yasunobu Matsumoto, Satoshi Wada, Yoko Aida |
| 20 |
[GO] |
2022―Sep―22 |
In silico prediction of COVID-19 cytokine storm in lung cancer types |
Surabhi Suchanti, Sonali Awasthi, Gyanendra Singh, Pramod K. Yadav, Abhijeet Singh, Rajeev Mishra |
| 21 |
[GO] |
2022―Sep―13 |
Simple neutralization test report: Do probiotics contribute to COVID-19 therapy? |
Anna Surgean Veterini, Cita Rosita Sigit Prakoeswa, Damayanti Tinduh, Satuman Satuman |
| 22 |
[GO] |
2022―Jul―01 |
High-resolution melting analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2 |
Takuro Koshikawa, Hiroshi Miyoshi |
| 23 |
[GO] |
2022―Apr―21 |
Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19) |
Hamid Behrouj, Omid Vakili, Adel Sadeghdoust, Neda Aligolighasemabadi, Parnian Khalili, Mozhdeh Zamani, Pooneh Mokarram |
| 24 |
[GO] |
2022―Feb―01 |
Common genetic aspects between COVID-19 and sarcoidosis: A network-based approach using gene expression data |
Md. Roman Mogal, Sagarika Adhikary Sompa, Asadullah Junayed, Md. Rashel Mahmod, Md. Zainul Abedin, Md. Asaduzzaman Sikder |
| 25 |
[GO] |
2022―Jan―31 |
Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations |
Samia E. Omer, Tawasol M. Ibrahim, Omer A. Krar, Amna M. Ali, Alaa A. Makki, Walaa Ibraheem, Abdulrahim A. Alzain |
| 26 |
[GO] |
2021―Dez―15 |
Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia |
David Bovard, Marco van der Toorn, Walter K. Schlage, Samuel Constant, Kasper Renggli, Manuel C. Peitsch, Julia Hoeng |
| 27 |
[GO] |
2021―Nov―10 |
Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein |
Gulam Rabbani, Saeyoung Nate Ahn, Hyunhwa Kwon, Khurshid Ahmad, Inho Choi |
| 28 |
[GO] |
2021―Jul―19 |
Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma |
Brandon Bergsneider, Elise Bailey, Yusuf Ahmed, Namrata Gogineni, Derek Huntley, Ximena Montano |
| 29 |
[GO] |
2021―Jul―06 |
Peptide inhibitors against SARS-CoV-2 2′-O-methyltransferase involved in RNA capping: A computational approach |
Mainak Dutta, Eldhose Iype |
| 30 |
[GO] |
2021―Jun―14 |
Shorter leukocyte telomere length is associated with severity of COVID-19 infection. |
Gabriel Arantes dos Santos, Ruan Pimenta, Nayara I. Viana, Vanessa R. Guimarães, Poliana Romão, Patrícia Candido, Juliana A. de Camargo, Diná M. Hatanaka, Paula GS. Queiroz, Alexandre Teruya, Katia R.M. Leite, Victor Srougi, Miguel Srougi, Sabrina T. Reis |
| 31 |
[GO] |
2021―Jun―03 |
In Silico Molecular Docking Analysis for Repurposing Approved Antiviral Drugs against SARS-CoV-2 Main Protease |
Ibrahim Khater, Aaya Nassar |
| 32 |
[GO] |
2021―Mai―25 |
Accommodating receptor flexibility and free energy calculation to reduce false positive binders in the discovery of natural products blockers of SARS-COV-2 spike RBD-ACE2 interface |
Marcelina Ogedjo, Isaac Onoka, Mtabazi Sahini, Daniel M. Shadrack |
| 33 |
[GO] |
2021―Mai―14 |
Sequence and structural analysis of COVID-19 E and M protein with MERS virus E and M protein-A comparative study |
Ebtisam A. Aldaais, Subha Yegnaswamy, Fatimah Albahrani, Fatima Alsowaiket, Sarah Alramadan |
| 34 |
[GO] |
2021―Mrz―29 |
Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor |
Tamim Ahsan, Abu Ashfaqur Sajib |
| 35 |
[GO] |
2021―Feb―27 |
In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis |
Azza H. Harisna, Rizky Nurdiansyah, Putri H. Syaifie, Dwi W. Nugroho, Kurniawan E. Saputro, Chandra D. Prakoso, Nurul T. Rochman, Nurwenda N. Maulana, Alfian Noviyanto, Etik Mardliyati |
| 36 |
[GO] |
2021―Feb―06 |
SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection |
Iman Hassan Ibrahim, Doha El-Sayed El-lakwa |
| 37 |
[GO] |
2021―Jan―27 |
Variations in Orf3a protein of SARS-CoV-2 alter its structure and function |
Gajendra Kumar Azad, Parimal Kumar Khan |
| 38 |
[GO] |
2020―Dez―29 |
Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan |
Walid Al-Zyoud, Hazem Haddad |
| 39 |
[GO] |
2020―Dez―12 |
Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing |
Resal Raj |
| 40 |
[GO] |
2020―Nov―05 |
SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes |
Vikas Kumar Bhari, Durgesh Kumar, Surendra Kumar, Rajeev Mishra |
| 41 |
[GO] |
2020―Okt―10 |
Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2 |
Gajendra Kumar Azad |
| 42 |
[GO] |
2020―Aug―20 |
ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity |
Fedaa Ali, Menattallah Elserafy, Mohamed H. Alkordi, Muhamed Amin |
